Tasimelteon

AbMole BioScience

Tasimelteon

9

609799-22-6

Chemical

Research Use Only

C15H19NO2

245.32

Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules.

CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2

12352200